Status:
UNKNOWN
Exercise Rehabilitation for Patients With Critical Limb Ischemia After Revascularization
Lead Sponsor:
University of Calgary
Conditions:
Peripheral Arterial Disease
Critical Limb Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peripheral arterial disease (PAD) affects more than 200 million people worldwide. This disease occurs with narrowing and occlusion of arteries supplying oxygenated blood to the organs and limbs. Sympt...
Detailed Description
Background: Peripheral arterial disease (PAD) refers to narrowing and occlusion of arteries supplying oxygenated blood to non-coronary and non-intracranial circulatory systems. This term is typically ...
Eligibility Criteria
Inclusion
- Ambulating prior to procedure
- Living independently prior to procedure
- Available to attend all SEP and follow-up appointments
- PAD Fontaine class III and IV (rest pain and tissue loss)
- Entry with consent of vascular surgeon
- Ischemia secondary to TASC A-D lesions identified on imaging (CTA or angiogram)
- Able to understand and sign informed consent
- \>18 years of age
Exclusion
- Confined to wheelchair
- Patients with exercise tolerance limitations due to other co-morbidities such as cardiorespiratory, musculoskeletal, or peripheral neuropathy. (NYHA class III and IV)
- PAD Fontaine class I and II (asymptomatic, claudication)
- Patients with ongoing tissue loss that limits ambulation
- Patient with previous revascularization procedures
- Patients undergoing revascularization for acute limb ischemia events
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03839953
Start Date
February 15 2019
End Date
July 1 2020
Last Update
May 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peter Lougheed Center, Alberta Health Services, University of Calgary
Calgary, Alberta, Canada, T1Y 6J4